Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 429302678 series 2912274
Content provided by Sound Optometry. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sound Optometry or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Gene therapy is one of the most exciting areas of modern medicine. In eye care, they promise to restore the vision of patients with both rare genetic eye diseases, such as a certain type of inherited retinal dystrophy, as well as more common conditions that have genetic components, like AMD.
In this episode, Michelle Hanratty uncovers how gene therapies work with Omar Mahoo, a consultant ophthalmologist at Moorfields Eye Hospital, St Thomas’ Hospital and University College London. Michelle also hears about the first NHS approved ocular gene therapy programme, with Robert Henderson, a consultant paediatric ophthalmologist at Great Ormond Street Hospital and Moorfields Eye Hospital. Robert demonstrates the impact that gene therapies can have on patients and how optometrists can play an important role in supporting these treatments.
If you have a topic in mind that you’d like us to cover, or if you’ve got an interesting case study you’d like to share, send Docet a message on LinkedIn.
This episode covers the GOC domains of Communication and Clinical Practice. Docet - dedicated to providing quality optometric education and professional development.
In this episode, Michelle Hanratty uncovers how gene therapies work with Omar Mahoo, a consultant ophthalmologist at Moorfields Eye Hospital, St Thomas’ Hospital and University College London. Michelle also hears about the first NHS approved ocular gene therapy programme, with Robert Henderson, a consultant paediatric ophthalmologist at Great Ormond Street Hospital and Moorfields Eye Hospital. Robert demonstrates the impact that gene therapies can have on patients and how optometrists can play an important role in supporting these treatments.
If you have a topic in mind that you’d like us to cover, or if you’ve got an interesting case study you’d like to share, send Docet a message on LinkedIn.
This episode covers the GOC domains of Communication and Clinical Practice. Docet - dedicated to providing quality optometric education and professional development.
52 episodes
))
